Aehr Test Systems filings document material events, operating results, capital actions and governance matters for a semiconductor test and burn-in equipment company. Recent Form 8-K disclosures include quarterly financial-result releases covering revenue, bookings, backlog, cash position and GAAP and non-GAAP earnings measures.
The filing record also includes capital-structure disclosures tied to an at-the-market common stock offering under a Form S-3 registration statement, along with proxy and annual meeting materials. Those governance filings address director elections, shareholder voting results, amendments to the company’s equity incentive and employee stock purchase plans, auditor ratification and executive-compensation matters.
AEHR Test Systems EVP, PPBI Business Alberto Salamone reported that 204 shares were withheld on November 1, 2026, to satisfy tax withholding obligations upon vesting of restricted stock units; the footnote states this was not a sale. The transaction lists a price of $54.89 per share. His reported direct holdings after the transaction were 42,669 shares, including shares subject to unvested restricted stock units.
Aehr Test Systems reported first-quarter fiscal 2027 revenue of $33.0 million, up 200% year over year, and GAAP net income of $7.2 million, versus a $2.1 million loss a year earlier. Non-GAAP net income was $9.4 million. Bookings were $46.7 million; backlog was $100.9 million as of September 25, 2026, and effective backlog, including bookings received after quarter end, was $109.3 million as of November 1.
Aehr raised its fiscal 2027 revenue outlook to $150 million from a prior range of $130 million to $150 million and expects non-GAAP net income of at least 20% of revenue. A customer has decided to purchase a fully configured FOX-XP test cell for planned installation at a Taiwan OSAT partner in early calendar 2027. A high-volume production evaluation is planned, with a decision anticipated within several months after installation and validation.
Aehr is shipping and installing more than a dozen Sonoma systems per month for a lead hyperscale customer. Its second AI processor completed qualification and has follow-on orders for initial production sampling, with a production ramp anticipated in calendar 2027. Operating activities used $3.054 million cash, versus $282,000 in the three months ended August 29, 2025.
AEHR Test Systems director Narsing Krishna Vijayrao received a restricted stock unit award covering 2,169 shares of common stock on October 28, 2026, reported at 0.0000 per share. His direct holdings after the transaction were 3,169 shares, including shares subject to unvested restricted stock units. The award is subject to continued employment on vesting dates.
Aehr Test Systems appointed Narsing Vijayrao to its board, effective October 28, 2026, after increasing the authorized number of directors from six to seven. He joins the Compensation Committee and will serve until the next annual meeting of shareholders. The board determined that he qualifies as an independent director under Nasdaq listing standards.
Upon the effective date, Vijayrao will receive a $65,000 annual cash retainer and an initial RSU grant totaling $140,000, with the number of RSUs based on the stock price on the grant date. The initial grant vests in 1/16 increments on quarterly anniversaries over four years, subject to continued service. He will also be eligible for annual RSU grants totaling $140,000, vesting in 1/4 increments on quarterly anniversaries over one year, subject to continued service.
AEHR Test Systems director Narsing Krishna Vijayrao reported direct ownership of 1,000 shares of Common Stock as of October 28, 2026.
Alistair N. Sporck, VP Contactor Business Unit at AEHR TEST SYSTEMS, had 188 common shares withheld on October 27, 2026, to satisfy tax withholding obligations upon vesting of restricted stock units; the footnote says this was not a sale. He reported 21,665 directly held shares afterward, including shares subject to unvested restricted stock units, and a separate indirect holding of 6,398 shares by trust.
Aehr Test Systems executive Vernon Rogers, Exec VP of Sales & Mktg., had 197 common shares withheld on October 27, 2026, to satisfy tax withholding obligations upon vesting of restricted stock units; the footnote says this did not represent a sale. The reported price was $63.95 per share. Rogers' reported post-transaction position was 186,682 shares, including shares subject to unvested restricted stock units.
AEHR TEST SYSTEMS CTO Donald P. Richmond II had 145 shares withheld on October 27, 2026, to satisfy tax-withholding obligations upon vesting of restricted stock units; this was not a sale. The reported price was $63.95 per share. His reported post-transaction holdings were 186,583 shares, including shares subject to unvested restricted stock units. No Rule 10b5-1 plan is reported.
AEHR Test Systems President and CEO Gayn Erickson had 851 shares withheld on October 27, 2026, to satisfy tax-withholding obligations upon vesting of restricted stock units and restricted shares; this was not a sale. The reported price was $63.95 per share. After the transaction, his reported direct holdings were 190,257 shares, including unvested restricted stock units and restricted shares, and his reported indirect holdings through a trust were 158,776 shares.
AEHR TEST SYSTEMS Chief Operating Officer Adil Engineer had 202 shares of common stock withheld on October 27, 2026, to satisfy tax withholding obligations upon vesting of restricted stock units. The reported price was $63.95 per share; a footnote states this was not a sale by the reporting person. His reported direct holdings after the transaction were 45,740 shares, including shares subject to unvested restricted stock units.